Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1BELIMUMAB
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
2Belimumab 1 mg/kg
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
3Belimumab 10 mg
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 222 💬
4Belimumab 10 mg/kg
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 43, 46, 49 💬
5Belimumab 10 mg/kg plus standard therapy
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
6Belimumab 100 mg SC
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
7Belimumab 10mg/kg
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
8Belimumab 200 mg SC
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
9Belimumab 200 mg/mL
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
10Belimumab 4 mg/kg
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
11Belimumab for IV
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
12Belimumab for SC
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
13Belimumab in SLE patients / Rituximab in RA patients
(Benlysta)		2件: Belimumab (Benlysta),
Rituximab		2件: Rituximab ,
Belimumab (Benlysta) 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
14Belimumab Injection
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
15Belimumab Injection [Benlysta]1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
16Belimumab or benlysta1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
17Belimumab plus Early Vaccination
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
18Belimumab plus Late Vaccination
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
19Benlysta1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬5件: 43, 49, 53, 66, 222 💬
20Benlysta (belimumab)1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 11, 49, 53, 222 💬
21BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 53 💬
22Benlysta 400 mg powder for concentrate for solution for infusion1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 43, 49 💬
23Benlysta 400 mg powder for concentrate for solution for infusions1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
24Benlysta 400mg polvere per concentrato per soluzione per infusione1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 43 💬
25BENLYSTA? (belimumab)1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
26Benlysta®1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 49, 222 💬
27BENLYSTA® (belimumab)1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 11, 66, 222 💬
28BENLYSTA™ (belimumab)1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
29Combination of Rituximab with subcutaneous belimumab
(Benlysta)		2件: Belimumab (Benlysta),
Rituximab		2件: Rituximab ,
Belimumab (Benlysta) 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
30Combination Product: Belimumab
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
31GSK1550188 (Belimumab)
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 222 💬
32HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 49, 53 💬
33LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
34Prednisone and Belimumab
(Benlysta)		2件: Belimumab (Benlysta),
Prednisone		2件: Prednisone ,
Belimumab (Benlysta) 💬 		2件: NR3C1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬1件: 300 💬
35SC belimumab 200 mg
(Benlysta)		1件: Belimumab (Benlysta)1件: Belimumab (Benlysta) 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬